Qingdao Historical Cash Flow
| 688139 Stock | 33.28 0.36 1.09% |
Analysis of Qingdao Haier cash flow over time is an excellent tool to project Qingdao Haier Biomedical future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Investments of 265.4 M or Change In Cash of 341.8 M as it is a great indicator of Qingdao Haier ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Qingdao Haier Biomedical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Qingdao Haier Biomedical is a good buy for the upcoming year.
Qingdao |
About Qingdao Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Qingdao balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Qingdao's non-liquid assets can be easily converted into cash.
Qingdao Haier Cash Flow Chart
Add Fundamental
Capital Expenditures
Capital Expenditures are funds used by Qingdao Haier Biomedical to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Qingdao Haier operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Qingdao Haier Biomedical financial statement analysis. It represents the amount of money remaining after all of Qingdao Haier Biomedical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from Qingdao Haier's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Qingdao Haier Biomedical current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Qingdao Haier Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Qingdao Haier's Change To Inventory is projected to increase significantly based on the last few years of reporting. The current year's Investments is expected to grow to about 265.4 M, whereas Net Borrowings is projected to grow to (22.8 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Capital Expenditures | 204.7M | 294.2M | 177.2M | 143.6M | Depreciation | 48.3M | 64.1M | 102.7M | 107.8M |
Qingdao Haier cash flow statement Correlations
Click cells to compare fundamentals
Qingdao Haier Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Qingdao Haier cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (54.2M) | (115.6M) | (99.1M) | 76.8M | 38.3M | 40.3M | |
| Investments | 499.7M | 320.4M | (1.8B) | 66.0M | 252.8M | 265.4M | |
| Change In Cash | 1.0B | 414.9M | (1.0B) | 183.9M | 325.5M | 341.8M | |
| Total Cashflows From Investing Activities | 373.3M | (135.2M) | (1.5B) | (251.2M) | (226.1M) | (237.4M) | |
| Depreciation | 11.4M | 22.9M | 48.3M | 64.1M | 102.7M | 107.8M | |
| Capital Expenditures | 168.4M | 89.0M | 204.7M | 294.2M | 177.2M | 143.6M | |
| Total Cash From Operating Activities | 149.0M | 280.5M | 696.6M | 632.4M | 249.3M | 413.8M | |
| Net Income | 182.1M | 381.0M | 845.0M | 600.8M | 406.1M | 373.0M | |
| End Period Cash Flow | 1.4B | 1.8B | 747.2M | 931.2M | 1.3B | 920.5M | |
| Other Cashflows From Investing Activities | 46.6M | 44.0M | 49.2M | 92.2M | 106.1M | 111.4M | |
| Change To Netincome | (14.5M) | 26.6M | (82.5M) | (483.6M) | (435.3M) | (413.5M) | |
| Change To Liabilities | 170.4M | 451.0M | 117.8M | (64.5M) | (74.2M) | (70.5M) | |
| Free Cash Flow | 112.1M | 607.6M | 387.1M | 338.2M | 72.1M | 68.5M | |
| Change In Working Capital | 66.9M | 400.8M | 86.1M | (25.3M) | (182.5M) | (173.3M) | |
| Begin Period Cash Flow | 350.2M | 1.4B | 1.8B | 747.2M | 931.2M | 854.5M | |
| Other Non Cash Items | 1.0M | 428.5K | (1.5M) | 668.8K | (9.3M) | (8.8M) | |
| Dividends Paid | 25.7M | 57.1M | 120.8M | 162.5M | 142.8M | 114.2M | |
| Change To Account Receivables | (56.4M) | 39.6M | 67.5M | (37.6M) | (43.2M) | (41.0M) |
Currently Active Assets on Macroaxis
Other Information on Investing in Qingdao Stock
The Cash Flow Statement is a financial statement that shows how changes in Qingdao balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Qingdao's non-liquid assets can be easily converted into cash.